Qualitek Labs FY26 PAT Rises 90% to ₹14.60 Crore
Qualitek Labs Limited reported a 90% YoY increase in consolidated net profit to ₹14.60 Crore for FY26, with revenue rising 77% to ₹124.52 Crore. The company announced a capex plan of INR 63 Crore for FY2026-27 to fund expansion in Transport, Minerals, and Food segments.
*this image is generated using AI for illustrative purposes only.
Qualitek Labs Limited has filed its investor presentation for the half-year and full year ended March 31, 2026, with the Bombay Stock Exchange. The presentation details the company's financial performance, operational highlights, and strategic initiatives for the period. The company reported robust growth across consolidated and standalone metrics driven by recent acquisitions and operational expansion.
Consolidated Financial Performance
For the financial year ended March 31, 2026, the company reported a consolidated net profit of ₹14.60 Crore, a rise of 90% from ₹7.68 Crore in the previous year. Revenue from operations increased to ₹124.52 Crore, up 77% from ₹70.23 Crore in FY25. Total income for the period stood at ₹125.05 Crore. The basic and diluted earnings per share (EPS) for the year were recorded at ₹13.4, compared to ₹7.08 in the prior year. EBITDA for the full year grew 80% to ₹29.29 Crore, with an EBITDA margin of 24%.
Key Consolidated Metrics
| Particulars | FY26 (₹ Lakh) | FY25 (₹ Lakh) |
|---|---|---|
| Revenue from Operations | 12451.81 | 7022.69 |
| Total Income | 12504.55 | 7074.27 |
| Total Expenses | 10666.53 | 6032.43 |
| Net Profit | 1460.15 | 768.36 |
| EPS (Basic) | 13.38 | 7.08 |
Standalone Financial Results
On a standalone basis, Qualitek Labs Limited reported a net profit of ₹8.0 Crore for FY26, an increase of 51% from the previous year. Revenue from operations for the year stood at ₹67.60 Crore, compared to ₹45.86 Crore in FY25. Basic and diluted EPS for the standalone entity were ₹7.3, up from ₹5.94 in the preceding year. For H2 FY26, standalone revenue was ₹38.6 Cr, while PAT stood at ₹5.2 Cr.
Key Standalone Metrics
| Particulars | FY26 (₹ Lakh) | FY25 (₹ Lakh) |
|---|---|---|
| Revenue from Operations | 6762.45 | 4586.48 |
| Total Income | 6786.06 | 4601.74 |
| Total Expenses | 5822.82 | 3891.06 |
| Net Profit | 796.44 | 528.33 |
| EPS (Basic) | 7.30 | 5.94 |
Corporate Developments and Outlook
The company outlined a capital expenditure plan of INR 63 Crore for FY2026-27. Strategic initiatives include geographic expansion in Transport and Minerals segments, capacity expansion of Food labs, and the establishment of new revenue streams such as EMI/EMC in Pune and an analytical lab in Noida. The company also plans to pursue M&A opportunities across Pharma, Food, and Electricals & Electronics segments.
Historical Stock Returns for Qualitek Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.18% | +11.04% | +13.89% | +5.97% | +32.68% | +104.51% |
How will Qualitek Labs finance its ₹63 Crore capex plan for FY2026-27, and could this lead to equity dilution or increased debt that might pressure future margins?
Which specific acquisition targets in the Pharma, Food, and Electricals & Electronics segments is Qualitek Labs likely to pursue, and how might these deals impact its consolidated EBITDA margin beyond the current 24%?
Given that consolidated revenue growth (77%) significantly outpaced standalone revenue growth (47%), how dependent is Qualitek Labs on its acquired subsidiaries for sustaining this growth trajectory if integration challenges arise?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
